Patients' preferences in choosing therapy for retinal vein occlusions
- PMID: 17621191
- DOI: 10.1097/IAE.0b013e31802c0a34
Patients' preferences in choosing therapy for retinal vein occlusions
Abstract
Purpose: The purpose of this study was to assess preference values for vein occlusions with macular edema and to determine how this may affect patient perceptions of potential treatments.
Methods: The Submacular Surgery Trials Vision Preference Value Scale and questions regarding enthusiasm for potential treatments were administered to 153 patients with vein occlusion. Univariate analyses identified predictors of preference values, followed by adjustment for potential confounders using multivariate linear regression. Relationships between preference values and enthusiasm for potential treatments were assessed.
Results: The mean preference values +/- SD were similar for patients with branch vein occlusions and central vein occlusions (0.65 +/- 0.20). Lower preference values were associated with duration of occlusion of >2 years (P=0.03) and poorer last-recorded visual acuity (P=0.02). Approximately one half of patients were moderately or very enthusiastic about undergoing intravitreal injection. Sixty-nine percent of branch vein occlusion patients were moderately or very enthusiastic about the standard of care, laser photocoagulation; only one third of central vein occlusion patients were moderately or very enthusiastic about standard observation.
Conclusions: These data suggest that vein occlusion with macular edema has a significant impact on quality of life. Most patients were willing to undergo potentially invasive treatment.
Similar articles
-
Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.Retina. 2008 Mar;28(3):465-72. doi: 10.1097/IAE.0b013e318154b9d1. Retina. 2008. PMID: 18327140
-
Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions.Ophthalmology. 2008 Oct;115(10):e47-54. doi: 10.1016/j.ophtha.2008.06.021. Epub 2008 Aug 16. Ophthalmology. 2008. PMID: 18708258 Clinical Trial.
-
Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion.Ophthalmic Res. 2008;40(1):26-31. doi: 10.1159/000111155. Epub 2007 Nov 20. Ophthalmic Res. 2008. PMID: 18025838
-
Branch retinal vein occlusion: classification and treatment.Ophthalmologica. 2009;223(5):298-305. doi: 10.1159/000213640. Epub 2009 Apr 16. Ophthalmologica. 2009. PMID: 19372724 Review.
-
Retinal vein occlusion: beyond the acute event.Surv Ophthalmol. 2011 Jul-Aug;56(4):281-99. doi: 10.1016/j.survophthal.2010.11.006. Epub 2011 May 24. Surv Ophthalmol. 2011. PMID: 21601903 Review.
Cited by
-
Vision Preference Value Scale and Patient Preferences in Choosing Therapy for Symptomatic Vitreomacular Interface Abnormality.JAMA Ophthalmol. 2018 Jun 1;136(6):658-664. doi: 10.1001/jamaophthalmol.2018.1272. JAMA Ophthalmol. 2018. PMID: 29800983 Free PMC article.
-
Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion.Clin Ophthalmol. 2011;5:1043-9. doi: 10.2147/OPTH.S13775. Epub 2011 Jul 26. Clin Ophthalmol. 2011. PMID: 21845032 Free PMC article.
-
Comparison of injection of intravitreal drugs with standard care in macular edema secondary to branch retinal vein occlusion.Korean J Ophthalmol. 2014 Feb;28(1):19-25. doi: 10.3341/kjo.2014.28.1.19. Epub 2014 Jan 21. Korean J Ophthalmol. 2014. PMID: 24505197 Free PMC article. Clinical Trial.
-
Treatment Patterns of Anti-Vascular Endothelial Growth Factor and Laser Therapy Among Patients with Diabetic Macular Edema.J Manag Care Spec Pharm. 2015 Sep;21(9):735-41. doi: 10.18553/jmcp.2015.21.9.735. J Manag Care Spec Pharm. 2015. PMID: 26308221 Free PMC article.
-
Intravitreal bevacizumab alone or combined with macular laser photocoagulation for recurrent or persistent macular edema secondary to branch retinal vein occlusion.J Ophthalmol. 2014;2014:173084. doi: 10.1155/2014/173084. Epub 2014 Jul 7. J Ophthalmol. 2014. PMID: 25114799 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources